TÜRKÇE
ENGLISH
Information
| Unit | FACULTY OF PHARMACY |
| PHARMACY PR. | |
| Code | ECS401 |
| Name | Pharmaceutical dosage forms and modern therapeutic systems |
| Term | 2020-2021 Academic Year |
| Semester | 7. Semester |
| Duration (T+A) | 2-0 (T-A) (17 Week) |
| ECTS | 2 ECTS |
| National Credit | 2 National Credit |
| Teaching Language | Türkçe |
| Level | Belirsiz |
| Type | Normal |
| Label | E Elective |
| Mode of study | Uzaktan Öğretim |
| Catalog Information Coordinator | Dr. Öğr. Üyesi ESRA DEMİRTÜRK |
| Course Instructor |
Dr. Öğr. Üyesi ESRA DEMİRTÜRK
(Güz)
(A Group)
(Ins. in Charge)
Doç. Dr. UMAY MERVE GÜVEN BÖLGEN (Güz) (A Group) (Asst. Ins.) |
Course Goal / Objective
The aim of the course is to introduce students to the introduction of modern therapeutic systems, ways of using drugs and the reasons for the development of modern therapeutic systems and the importance of biopolymers in the design of modern therapeutic systems.
Course Content
Recent developments and new approaches in the development of pharmaceutical dosage forms, introduction of modern therapeutic systems
Course Precondition
Resources
Notes
Course Learning Outcomes
| Order | Course Learning Outcomes |
|---|---|
| LO01 | Define modern therapeutic systems. |
| LO02 | Have knowledge about ways and designs of modern therapeutic systems. |
| LO03 | Understands the reasons for the development of modern therapeutic systems. |
| LO04 | Explain the importance of biopolymers in modern therapeutic system design. |
| LO05 | Explain the properties and importance of micro and nanoparticular systems. |
| LO06 | Explains pharmacopoeial and legal regulations related to modern therapeutic systems and medical devices. |
Relation with Program Learning Outcome
| Order | Type | Program Learning Outcomes | Level |
|---|---|---|---|
| PLO01 | - | Have sufficient knowledge in pharmaceutical field and develop the knowledge gained. | 5 |
| PLO02 | - | Applies the profession in accordance with the existing laws and regulations,gains awareness of professional and ethical responsibility. | 4 |
| PLO03 | - | It serves the society as a pharmacist who is loyal to Atatürk's principles and reforms, equipped with Universal Knowledge, who uses Turkish correctly and knows at least one foreign language. | 4 |
| PLO04 | - | Communicates effectively both orally and in writing. | 5 |
| PLO05 | - | External appearance, attitude, attitude and behavior, with professional identity, role model and society becomes an example to colleagues. | 5 |
| PLO06 | - | Provides consultancy services to patients, community and health care personnel with a wide range of information on the drug,evaluates advanced knowledge and skills with a critical approach. | 4 |
| PLO07 | - | Possessing the knowledge of historical and current developments in the field of Pharmacy, monitoring, evaluation and application of scientific and evidence-based data, and adopting lifelong learning. | 5 |
| PLO08 | - | Have knowledge about health policies and health economics, pharmacy management and define the problems in pharmaceutical field. | 4 |
| PLO09 | - | Interprets information about current health and treatment problems. Plays an active role in community health. | 4 |
| PLO10 | - | Pharmacy integrates and develops professional knowledge with information from different disciplines and uses the acquired knowledge to improve the health level and quality of life of the community. | 4 |
| PLO11 | - | Students will be able to use the concepts and applications of basic sciences and basic medical sciences effectively in the field of Medicine and pharmacy and have the experience of working with these health sciences. | 4 |
| PLO12 | - | Acquires basic information about diseases, adopts and applies rational drug use on all drugs that affect systems. | 4 |
| PLO13 | - | By learning the basics of Clinical Pharmacy,will have the knowledge and skills to help provide drug/patient oriented pharmacy applications and individualized Pharmaceutical Care. | 4 |
| PLO14 | - | It plays a role in the evaluation and analysis of the events and cases related to the development of pharmacy profession and education. | 5 |
Week Plan
| Week | Topic | Preparation | Methods |
|---|---|---|---|
| 1 | Introduction to Modern Therapeutic Systems | Observation--Research | |
| 2 | Reasons for Drug Use and Development of Modern Therapeutic Systems | Observation--Research | |
| 3 | The Importance of Biopolymers in the Design of Modern Therapeutic Systems | Observation--Research | |
| 4 | Modern Transdermal Systems | Observation--Research | |
| 5 | Intraocular and Osmotic Systems | Observation--Research | |
| 6 | Bioadhesive and Oral Mucosal Systems | Observation--Research | |
| 7 | Pharmaceutical Implants, Recent Developments and Uses | Observation--Research | |
| 8 | Mid-Term Exam | Observation--Research | |
| 9 | Krono Pharmaceuticals | Observation--Research | |
| 10 | Micro Particulate Systems | Observation--Research | |
| 11 | Nano Particulate Systems | Observation--Research | |
| 12 | Pharmacopoeial Regulations Related to Modern Therapeutic Systems | Observation--Research | |
| 13 | Legal Regulations Related to Modern Therapeutic Systems | Observation--Research | |
| 14 | Pharmacopoeial Regulations Regarding Medical Devices | Observation--Research | |
| 15 | Legal Regulations Related to Medical Devices | Observation--Research | |
| 16 | Term Exams | Observation--Research | |
| 17 | Term Exams | Observation--Research |
Assessment (Exam) Methods and Criteria
Current term shares have not yet been determined. Shares of the previous term are shown.
| Assessment Type | Midterm / Year Impact | End of Term / End of Year Impact |
|---|---|---|
| 1. Midterm Exam | 100 | 40 |
| General Assessment | ||
| Midterm / Year Total | 100 | 40 |
| 1. Final Exam | - | 60 |
| Grand Total | - | 100 |